Kriger Research Group International Joins TrialStat's CROFirst Program

Share Article

Worldwide Contract Research Organization (CRO) Deploys ClinicalAnalytics 4.0 for its Clinical Trials

Our team was able to adopt CA 4.0 quickly due to its configurability and minimal training requirements. We view our involvement with TrialStat's CROFirst program as a mutually beneficial partnership.

TrialStat Corporation , the industry's first clinical data solutions on demand company, today added Kriger Research Group International (KRC), a worldwide CRO specializing in the bio-medical field, to its CROFirst Program. The enhancements of TrialStat's CRO channel program, announced on April 9th, provides discounts that promote mutually beneficial business development and marketing initiatives between TrialStat and its CRO partners. As a member of CROFirst, KRC can utilize program discounts on its CA 4.0 licenses to grow its bottom line and expand its business in partnership with TrialStat in North America, the United Kingdom, Israel, India and the Western Pacific Region.

"The flexibility, functionality, speed and ease of use were the primary reasons behind our selection of TrialStat's CA 4.0," said Bruce Kriger, Chief Executive Officer, Kriger Research Group International. "Our team was able to adopt CA 4.0 quickly due to its configurability and minimal training requirements. We view our involvement with TrialStat's CROFirst program as a mutually beneficial partnership."

"We place a lot of value in Kriger Research Group International's participation in our CROFirst program ," said Jonathan Barker, President and CEO, TrialStat. "This joint partnership enables both TrialStat and KRC to more effectively collaborate on activities that encourage the mutually beneficial adoption of CA 4.0 in the growing bio-medical field."

ABOUT TRIALSTAT
TrialStat Corporation provides innovative clinical data solutions on demand that optimize the collection and management of research to enable customers to accelerate the commercialization of new life science products. CA 4.0 is a robust and scalable Web-based EDC on demand platform used by leading biopharma organizations. SRS 4.0® automates systematic reviews using real-time collaboration and management tools, while ESRNexus™ (http://www.esrnexus.com) is the most comprehensive and free Web-based search engine for evidence-based reference literature. More information about TrialStat is available at http://www.trialstat.com.

ABOUT KRIGER GROUP RESEARCH INTERNATIONAL
Kriger Research Group International is a family of several companies within the bio-pharmaceutical industry, with each company serving a separate, specific role, working in conjunction with each other to better accommodate the client's needs through operational relations.

Kriger Group is also a global network of institutions connected by common aims and areas of interest. KRC Centers act as research organizations in the USA, Canada, UK , Israel, India and Western Pacific Region , performing a broad range of researches in bio-medical fields, acting as contract research organizations, scientific, publishing and training centers for clinical research and medical professionals worldwide. Other companies within the group cover recruitment, professional listing and other areas of activities within the bio-pharmaceutical industry.

ClinicalAnalytics 4.0 and ESRNexus are registered trademarks of TrialStat Corporation.

SRS 4.0 is a trademark of TrialStat Corporation.

For media inquiries, please contact:
Muay Lim
TrialStat Corporation
613-741-9909 ext 153
mlim @ trialstat.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Muay Lim

1-617-747-1000 814
Email >